Announcements Trials

Browse Landscape

Phase

Status

Completed 5 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Urinary Bladder Neoplasms 1 Non-Muscle Invasive Bladder Neoplasms 1 Carcinoma, Hepatocellular 1 Advanced Cancer 1

Interventions

Nivolumab 6 Ipilimumab 4 6-(6-(1-methyl-1H-pyrazol-4-yl)-(1,2,4)triazolo(4,3-b)pyridazin-3-ylsulfanyl)quinoline 2 tilsotolimod 1 relatlimab 1 mirdametinib 1 linrodostat 1 gedatolisib 1 figitumumab 1 Valganciclovir 1 Tablets 1 Surveys and Questionnaires 1 Sunitinib 1 Paclitaxel 1 LY2584702 1 Irinotecan 1 EC145 1 Dasatinib 1 Chlorogenic Acid 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Advanced Cancer × linrodostat × Clear all

NCT02750514 2021-03-22

FRACTION-Lung

Bristol-Myers Squibb

Phase 2 Terminated

295 enrolled 21 charts

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡